{
    "clinical_study": {
        "@rank": "146362", 
        "arm_group": [
            {
                "arm_group_label": "Conventional Intravenous Fluid therapy", 
                "arm_group_type": "No Intervention", 
                "description": "Basal infusion of crystalloid (normal saline,Ringer's lactate,Ringer's solution)variable from 4 to 12 ml/kg/hour"
            }, 
            {
                "arm_group_label": "GDT", 
                "arm_group_type": "Experimental", 
                "description": "Basal infusion of crystalloids (normal saline,Ringer's lactate,Ringer's solution) at 2,5 ml/kg/h and boluses of crystalloids for values of  stroke volume (SV) <  SV TRIGGER.  Every additional infusion of colloids, blood derivates, drugs must be recorded"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid\n      Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using\n      automated pulse contour analysis (Flotrac/Vigileo\u00ae). A specific dedicated software has been\n      developed to perform clinical and expenditures data collection, both retrospective and\n      prospective data are archived."
        }, 
        "brief_title": "Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy", 
        "condition": "Postoperative Complications", 
        "condition_browse": {
            "mesh_term": "Postoperative Complications"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients selected for major abdominal surgery\n\n        Exclusion Criteria:\n\n        \u2022Patients under the age of 18, patients with hemodynamically significant aortic\n        regurgitation and heart rhythm disorders"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01995786", 
            "org_study_id": "19.11"
        }, 
        "intervention": {
            "arm_group_label": "GDT", 
            "intervention_name": "Goal Directed Fluid Therapy FloTrac/Vigileo", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fluid Therapy", 
            "Cost-Benefit Analysis", 
            "Hemodynamics", 
            "Cost Control"
        ], 
        "lastchanged_date": "November 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "zip": "00144"
                }, 
                "name": "Regina Elena CI"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "forastiere@ifo.it", 
            "last_name": "Ester Forastiere, M.D."
        }, 
        "overall_official": {
            "affiliation": "Regina Elena CI", 
            "last_name": "Ester Forastiere", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "rate of reduction of postoperative spending", 
            "safety_issue": "No", 
            "time_frame": "30 day postoperative"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01995786"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Regina Elena Cancer Institute", 
            "investigator_full_name": "Ester Forastiere", 
            "investigator_title": "chief", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Regina Elena Cancer Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Regina Elena Cancer Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}